Flash 7 is required to view this content. Download Flash 7.
Advancing Life Science Together ®
En tant que scientifiques et ingénieurs, pionniers des nouveaux traitements pour lutter contre les problèmes de santé qui défient l'humanité, vous comptez sur Millipore, votre partenaire de confiance depuis plus de 50 ans qui vous soutient par un continuum d'outils, de technologies et de solutions d'avant-garde, pour assurer le succès de vos recherches, vos développements et votre production.

Autres secteurs
Diagnostic & OEM, Vaccins, Boissons, Eau potable et eaux de rejet, Pharmacie hospitalière et Microélectronique.
Espace médias

Millipore Reports Third Quarter 2009 Financial Results
Millipore reported financial results for its third quarter ended October 3, 2009. Revenues for the third quarter grew 4 percent from the previous year, totaling $412 million. Excluding a 3 percent unfavorable impact from changes in foreign currency, Millipore generated organic revenue growth of 7 percent. On a divisional basis, excluding changes in foreign currency, Millipore’s Bioprocess Division generated organic revenue growth of 8 percent, while the Company’s Bioscience Division generated organic revenue growth of 4 percent from the previous year.........

Millipore Corporation named Corporate Citizen of the Year
Corporate commitment to reduce global carbon footprint through clean energy is lauded

Millipore and Roka Bioscience to Develop Real-Time Molecular Tests for Biopharmaceutical Applications
Millipore announced that it will collaborate with Roka Bioscience, Inc. to develop molecular assays and portable instruments...









